Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 1401

Researchers have quantified a pathway for the formation of molecular oxygen from the interaction of carbon dioxide with electrons, key information for searches of life on other worlds.

So far, life is only known to exist on Earth. But that hasn’t stopped scientists from searching for signs of living creatures on other planets. Those searches intensified with the deployment of the JWST observatory, which astronomers are using to characterize the atmospheres of far-off worlds in the hope of finding the signals of molecules that signify the presence of life (see News Feature: The Skinny on Detecting Life with the JWST). But for that to work, scientists need to know all the possible sources of atmospheric molecules. Now Lucas Sigaud of the Fluminense Federal University, Brazil, and his colleagues have uncovered a pathway for forming an oxygen molecule (O2]. The detailed measurements of the pathway provide key inputs for models used in planetary-life searches.

Read more | >

Atmospheric water generators can save millions of lives due to new drought conditions even bringing water from air in the desert climates.

  • Water scarcity continues to be a pervasive global challenge, cutting across developed and emerging markets, climates and socio-political dynamics.
  • Atmospheric water generation (AWG) technology is a promising emergency solution that can immediately generate drinkable water using moisture in the air.
  • Distribution of atmospheric water generation technology to communities in need can serve as an effective stopgap measure for municipalities facing immediate clean water shortages.

The statistics underpinning water scarcity are dire and noteworthy – approximately 770 million people lack access to clean water. That is one in ten people on the planet. The average woman in rural Africa walks 6 kilometres (about 3.7 miles) daily to haul 40 pounds of water.

Continue reading “See how atmospheric water generators can help water security” | >

Scientists seem to be close to creating a “one-and-done” vaccine that can protect against any strain of a virus with just one shot.

In a press release from the University of California — Riverside, one of the researchers behind the new RNA vaccine, Rong Hai, explained why he and his colleagues are so excited about their experimental — and allegedly universal — shot.

“What I want to emphasize about this vaccine strategy is that it is broad,” said Hai, a virologist and coauthor of a new paper on the vaccine candidate in the Proceedings of the National Academy of Sciences. “It is broadly applicable to any number of viruses, broadly effective against any variant of a virus, and safe for a broad spectrum of people.”

Read more | >

Scientists have demonstrated that facial recognition technology can predict a person’s political orientation with a surprising level of accuracy.

Researchers have demonstrated that facial recognition technology can predict political orientation from neutral expressions with notable accuracy, posing significant privacy concerns. This finding suggests our faces may reveal more personal information than previously understood.

Read more | >

We lost a really great human today – philosopher Daniel C. Dennett.

Dan was a kind, honest, generous guy. He had a brilliant mind – insightful, critical, with an encyclopedic knowledge of pithy analogies and clinical examples (“intuition pumps” he called them), as well as who came up with them. And despite all of his experience and accomplishments, he always had a kind of childish excitement about new ideas, and new experiments. What he liked best was new insights, wild ideas, honest argument. I first heard the concept of “steel-manning” from him (opposite of “straw man” – putting forth the strongest, best version of an argument you want to critique). He was not interested in cheap wins or rhetorical bullying – he wanted to get to the best version of every story about nature and about ourselves.

I first came into contact with Dan through his books. As a teenager, Brainstorms, Elbow Room, and The Intentional Stance were a fantastic introduction to the most interesting questions, and ways of thinking about them. My dad and I would hit the bookstores every Saturday and there was no way a Dennett book would escape us if a new one came out. We had lots of great times discussing the topics in his books. I eventually was able to ask Dan to sign a few of them for dad, as birthday presents.

Read more | >

From Carnegie Mellon and Meta.

TriForce.

Lossless Acceleration of Long Sequence Generation with Hierarchical Speculative Decoding.

With large language models (LLMs) widely deployed in long content generation recently, there has emerged an increasing demand for…

Continue reading “Paper page — TriForce: Lossless Acceleration of Long Sequence Generation with Hierarchical Speculative Decoding” | >

Humanoid robots are robots that resemble and act like humans. Typically engineered to imitate authentic human expressions, interactions and movements, these robots are often outfitted with an array of cameras, sensors and, more recently, AI and machine learning technologies.

While more humanoid robots are being introduced into the world and making a positive impact in industries like logistics, manufacturing, healthcare and hospitality, their use is still limited, and development costs are high.

That said, the sector is expected to grow. The humanoid robot market is valued at $1.8 billion in 2023, according to research firm MarketsandMarkets, and is predicted to increase to more than $13 billion over the next five years. Fueling that growth and demand will be advanced humanoid robots with greater AI capabilities and human-like features that can take on more duties in the service industry, education and healthcare.

Read more | >

T-Cell Priming Immunotherapies To Provide Broad And Robust, Long-Term Immunity — Prof. Dr. Thomas Rademacher, MD, PhD — CEO & Co-Founder, Emergex Vaccines

Professor Dr. Thomas Rademacher, MD, PhD, is CEO and Co-Founder of Emergex (https://emergexvaccines.com/), a company that has developed a novel nanoparticle-based vaccine technology to deliver synthetic viral fragments via microneedles on a skin-adhesive patch. Emergex’s approach works on the principle of priming immune T-cells, opening the door for the development of universal vaccines against highly mutagenic viruses such as the seasonal flu and covid. T-cell priming offers a superior inoculation strategy over traditional vaccines, which rely on the body’s generation of antibodies and fail to keep up with seasonal mutations.

A serial entrepreneur, Professor Rademacher also serves as Emeritus Professor of Molecular Medicine at University College London (UCL) and is widely considered one of the founders of biotech from the early 1980s (having been involved in many of it’s core disciplines – from recombinant proteins, to monoclonal antibodies, to glycobiology).

Continue reading “Prof. Dr. Thomas Rademacher, MD, PhD — CEO & Co-Founder, Emergex — T-Cell Priming Immunotherapies” | >

Is the Founder and CEO of Torigen Pharmaceuticals (https://www.torigen.com/), a company dedicated to researching and developing novel immuno-oncology products and services specifically for the veterinary market, with a focus on autologous cancer vaccines.

Torigen Pharmaceuticals is a start‑up that resulted from Ashley’s graduate thesis project at the University of Notre Dame, as she was working on her Masters in Engineering, Science and Technology Entrepreneurship in collaboration with Dr. Mark Suckow (https://www.research.uky.edu/staff/ma…). Ashley also received an undergraduate degree in Veterinary Pathology and Pathobiology from University of Connecticut.

Read more | >